Walleye Capital LLC Chimerix Inc Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.35 $11,038 - $15,533	6,610 Added 35.51%	25,227 $46,000
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $717,203 - $1.09 Million	-396,245 Reduced 95.51%	18,617 $36,000
Q2 2022 Aug 08, 2022	BUY	$1.34 - $5.34 $555,915 - $2.22 Million	414,862 New	414,862 $863,000
Q2 2019 Aug 14, 2019	SELL	$2.05 - $4.32 $88,010 - $185,466	-42,932 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.79 - $3.12 $76,848 - $133,947	42,932 New	42,932 $90,000

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.